乾燥細胞培養痘そうワクチンの効能追加承認について｜厚生労働省
https://www.mhlw.go.jp/stf/newpage_27201.htmlBundle the HTML, screenshot, summaries, and metadata into one ZIP file. Pro saves automatically start preparing the external RFC 3161 timestamp, and only unfinished records need one more preparation step before download.
乾燥細胞培養痘そうワクチンの効能追加承認について｜厚生労働省
Open the dedicated viewer to inspect the saved page with archive metadata pinned above it.
This is a self-contained HTML copy with CSS and images embedded, so it still renders even if the original page disappears.
The dedicated viewer keeps the original URL and saved timestamp visible while you review the archived HTML.
This page announces the Japanese Ministry of Health, Labour and Welfare's approval of an additional indication for dried cell culture smallpox vaccine on August 2, 2022. KM Biologics Co., Ltd.'s product "Dried Cell Culture Smallpox Vaccine LC16 'KMB'" received approval for monkeypox prevention in addition to its existing smallpox prevention indication. The application was submitted on July 6, 2022, and the approved efficacy now covers prevention of both smallpox and monkeypox.
